Moreover, the expression of the oncogene MYC is often augmented or activated in B cell malignancies and acts for example in DLBCL as a positive regulator of choline metabolism through augmented expression of Pcyt1a, a rate limiting enzyme in this pathway [34]. This evidence concerns the gene PCYT1A and diffuse large B-cell lymphoma.